Acanthe Developpement (XPAR:ACAN) Research & Development: €0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ACAN Acanthe Developpement SA XPAR:ACAN
41 GF Score
Price €0.22
GF Value €0.29
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Acanthe Developpement Research & Development?

Acanthe Developpement XPAR:ACAN 41 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates XPAR:ACAN with a GF Score™ of 41/100 and a GF Value™ of €0.29 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Acanthe Developpement's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Acanthe Developpement  (XPAR:ACAN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Acanthe Developpement Research & Development Related Terms

Acanthe Developpement Research & Development Historical Data

* Premium members only.

The historical data trend for Acanthe Developpement's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acanthe Developpement Research & Development Chart

Acanthe Developpement Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Acanthe Developpement Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XPAR:ACAN
41GF Score
Acanthe Developpement SA XPAR:ACAN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acanthe Developpement Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Acanthe Developpement (XPAR:ACAN) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Acanthe Developpement and its competitors.
Is Acanthe Developpement's Research & Development too high?
Acanthe Developpement's current Research & Development is €0.00 Mil. Overall, Acanthe Developpement has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acanthe Developpement's Research & Development compare to BXP and ARE?
Acanthe Developpement's Research & Development of €0.00 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Acanthe Developpement and its competitors. Acanthe Developpement's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acanthe Developpement stock overvalued right now?
Based on GuruFocus' analysis, Acanthe Developpement (XPAR:ACAN) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.29, compared to a current price of €0.22 — trading 24.1% below its estimated fair value. The current Research & Development is €0.00 Mil. Acanthe Developpement's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Acanthe Developpement (XPAR:ACAN), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acanthe Developpement (XPAR:ACAN) Overvalued in 2026?

Based on GuruFocus' analysis, Acanthe Developpement stock appears to be undervalued. The current stock price of €0.22 is trading 24.1% below its estimated GF Value™ of €0.29. GuruFocus considers Acanthe Developpement to be Modestly Undervalued.

Key valuation signals for XPAR:ACAN:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.29 vs. price of €0.22 (24.1% below fair value)
  • GF Score™: 41/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ACAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acanthe Developpement Business Description

Industry Real EstateREITs
Other Exchanges 0DYL:UKADX:Germany
Address 2, rue de Bassano, Paris, FRA, 75116
Acanthe Developpement SA is a European property company. Acanthe owns a property portfolio mainly located in the central business district of Paris. The company is organized into four principal operating segments Office Space, Commercial Premises, Hotels, and Residential. It has an operational presence in Belgium and France. All of the company's revenue is generated in the real estate sector in France and Brussels.
41GF Score

Get the complete analysis for XPAR:ACAN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.22
Price
€0.29
GF Value